Table 3.
Virtual Screening Results on 10 DUD Targetsa
Method | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Target | Average Similarity to Cognate Ligand | BCL::MolAlign | Maximum Common Substructure Similarity |
PL-PatchSurfer2 | |||||||
Actives | Decoys | AUC | ROCE1% | ROCE5% | AUC | ROCE1% | roce5% | AUC | ROCE1% | roce5% | |
ACHE | 0.45 ±0.21 | 0.20 ±0.07 | 0.9 | 71.6 | 15.3 | 0.9 | 95.6 | 28.8 | 0.7 | 28.6 | 7.2 |
CDK2 | 0.19 ±0.04 | 0.20 ± 0.04 | 0.5 | 2.1 | 3.0 | 0.4 | 0.0 | 0.4 | 0.5 | 109.9 | 6.6 |
ERA | 0.28 ±0.12 | 0.18 ±0.05 | 0.9 | 49.0 | 20.2 | 0.8 | 172.2 | 12.2 | 0.5 | 12.4 | 4.7 |
HIVPR | 0.13 ±0.04 | 0.12 ±0.03 | 0.7 | 1.9 | 3.2 | 0.6 | 2.0 | 0.4 | 0.7 | 121.8 | 11.9 |
NA | 0.34 ±0.14 | 0.14 ±0.07 | 0.9 | 107.0 | 19.9 | 0.9 | 10.3 | 25.4 | 0.5 | 29.6 | 3.1 |
P38 | 0.16 ±0.09 | 0.15 ±0.04 | 0.7 | 14.5 | 7.4 | 0.3 | 14.5 | 2.1 | 0.6 | 18.6 | 5.3 |
PPARG | 0.59 ±0.29 | 0.15 ±0.05 | 0.9 | 62.7 | 29.1 | 1.0 | 656.0 | 41.3 | 0.5 | 0.0 | 0.5 |
RXRA | 0.69 ±0.13 | 0.18 ±0.07 | 1.0 | 1.0 | 48.0 | 1.0 | 145.0 | 52.7 | 0.7 | 14.5 | 5.8 |
SRC | 0.14 ±0.03 | 0.18 ±0.06 | 0.6 | 1.7 | 2.1 | 0.2 | 0.0 | 0.0 | 0.6 | 148.3 | 10.0 |
THROMBIN | 0.15 ±0.06 | 0.14 ±0.05 | 0.8 | 1.6 | 1.6 | 0.7 | 1.5 | 1.3 | 0.6 | 10.3 | 6.2 |
Median | -- | -- | 0.8 | 8.3 | 11.4 | 0.8 | 12.4 | 7.2 | 0.6 | 23.6 | 6.0 |
Evaluation of the virtual screening performance of BCL::MolAlign compared to maximum common substructure similarity and PL-PatchSurfer2 on 10 targets originally reported by Shin et al.44 Similarity was measured as the maximum common connected substructure Tanimoto score. Substructures were defined by maching atoms by atomic numbers and bonds by bond order (with aromatic bonds given a distinct bond order), and ring membership.